CD47 polymorphism for predicting nivolumab benefit in patients with advanced non-small-cell lung cancer.
| Autor: | TATSUYA OGIMOTO1 ozahiro@kuhp.kyoto-u.ac.jp, HIROAKI OZASA1, HIRONORI YOSHIDA1, TAKASHI NOMIZO1, TOMOKO FUNAZO1, HIROSHI YOSHIDA1, KENTARO HASHIMOTO1, KAZUTAKA HOSOYA1, MASATOSHI YAMAZOE1, HITOMI AJIMIZU1, TAKAHIRO TSUJI1,2, YUICHI SAKAMORI1, KIYOMITSU KUNINAGA1, SATOSHI MORITA3, TOYOHIRO HIRAI1 |
|---|---|
| Zdroj: | Oncology Letters. Aug2023, Vol. 26 Issue 2, p1-7. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|